Benzimidazole Ring System as a Privileged Template for Anticancer Agents


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Cancer still remains a continued threat for human race in the 21st century. It is the major cause of human casualties globally and is thus, a hot topic of research in medicinal laboratories. Scientists are striving to find selective anticancer agents having low toxicity for normal human cells. Heterocyclic ring systems play key role as templates/pharmacophores for various drugs, and benzimidazole ring is especially important for its anticancer derivatives. In this review article, we have focused on the structural features of anticancer derivatives based on benzimidazole ring system. It highlights various benzimidazole-based anticancer compounds which have been developed in recent years.

Об авторах

Afshan Kanwal

Department of Chemistry, Government College University

Email: Matloob.Ahmad@gcuf.edu.pk
Пакистан, Faisalabad, 38000

Furqan Saddique

Department of Chemistry, Government College University

Email: Matloob.Ahmad@gcuf.edu.pk
Пакистан, Faisalabad, 38000

Sana Aslam

Department of Chemistry, Government College Women University

Email: Matloob.Ahmad@gcuf.edu.pk
Пакистан, Faisalabad, 38000

Matloob Ahmad

Department of Chemistry, Government College University

Автор, ответственный за переписку.
Email: Matloob.Ahmad@gcuf.edu.pk
Пакистан, Faisalabad, 38000

Ameer Zahoor

Department of Chemistry, Government College University

Email: Matloob.Ahmad@gcuf.edu.pk
Пакистан, Faisalabad, 38000

Noor-ul-Amin Mohsin

Faculty of Pharmaceutical Sciences, Government College University

Email: Matloob.Ahmad@gcuf.edu.pk
Пакистан, Faisalabad, 38000


© Springer Science+Business Media, LLC, part of Springer Nature, 2018

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах